TELA Bio, Inc.
TELA- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001561921
In the last 90 days, TELA Bio, Inc. insiders filed 4 open-market purchases and 0 sales; 45 institutions reported holding it in 13F filings for Q2 2026, worth $19.3M in total; no superinvestor holds it.
Q3 2021 vs. Q2 2021
How the institutions holding TELA Bio, Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 45 | 38 | −7 |
| Shares | 10.2M | 10.2M | +173 (0.0%) |
| Value | $164.9M | $139.8M | −$25.1M (−15.2%) |
New holders (2)
Institutions that held TELA Bio, Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Total Clarity Wealth Management, Inc. | 325 | $4.00K | 0.00% |
| Meridian Wealth Partners, LLC | 238 | $3.00K | 0.00% |
Sold out (9)
Institutions that held TELA Bio, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Millennium Management LLC | 61,078 | $984.0K |
| Jefferies Group LLC | 35,000 | $563.9K |
| Tibra Equities Europe Ltd | 12,900 | $208.0K |
| Walleye Capital LLC | 11,747 | $189.0K |
| Tower Research Capital LLC (TRC) | 1,083 | $17.0K |
| JPMorgan Chase & Co | 644 | $10.0K |
| Panagora Asset Management Inc | 278 | $4.00K |
| New York State Common Retirement Fund | 60 | $1.00K |
| Citigroup Inc | 1 | $0 |